233281-63-5

Basic information

• Product Name: methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-(tert-butoxycarbonylsulfamoyl)-N-[(E)-3-cyanocinnamyl]anthranilate
• Synonyms: methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-(tert-butoxycarbonylsulfamoyl)-N-[(E)-3-cyanocinnamyl]anthranilate
• CAS NO: 233281-63-5
• Molecular Weight: 670.784
• Mol File: 233281-63-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-(tert-butoxycarbonylsulfamoyl)-N-[(E)-3-cyanocinnamyl]anthranilate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-(tert-butoxycarbonylsulfamoyl)-N-[(E)-3-cyanocinnamyl]anthranilate(233281-63-5)
• EPA Substance Registry System: methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-(tert-butoxycarbonylsulfamoyl)-N-[(E)-3-cyanocinnamyl]anthranilate(233281-63-5)

Safety Data

• Hazardous Substances Data: 233281-63-5(Hazardous Substances Data)

Upstream product

• 179756-40-2 methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]anthranilate 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 1882-72-0 methyl 2-amino-5-hydroxybenzoate 
• 147000-89-3 N-tert-butyloxycarbonylsulfamoyl chloride 
• 233281-62-4 methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-[(E)-3-cyanocinnamyl]anthranilate 

Downstream Products

• 233596-33-3 3-{3-[2,2,4-trioxo-6-(piperidin-4-yloxy)-3,4-dihydro-2H-2λ⁶-benzo[1,2,6]thiadiazin-1-yl]-propenyl}-benzamidine 
• 540765-38-6 methyl 5-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]-N-(tert-butoxycarbonylsulfamoyl)-N-[3-(3-cyanophenyl)propyl]anthranilate 
• 233281-64-6 1-[(E)-3-cyanocinnamyl]-6-[(4-piperidyl)oxy]-1H-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide 

Relevant articles and documents

Design, synthesis and biological activity of YM-60828 derivatives. Part 2: Potent and orally-bioavailable factor Xa inhibitors based on benzothiadiazine-4-one template

Compound YM-60828 was previously characterized in our laboratory as a potent, selective and orally-bioavailable Factor Xa (FXa) inhibitor. The L-shape conformation of this compound in the active site of FXa was recognized as an important factor in display